Related Experiment Videos
Heart mitochondrial function in chronic experimental diabetes in rats.
The Canadian Journal of Cardiology
|January 1, 1985
Summary
Diabetic cardiomyopathy in rats stems from impaired heart mitochondrial function, evidenced by reduced respiration and ATP production. Insulin therapy effectively reversed these mitochondrial defects, suggesting a therapeutic target for diabetic heart disease.
Area of Science:
- Biochemistry
- Cardiology
- Metabolic Diseases
Background:
- Diabetes mellitus is a complex metabolic disorder associated with numerous cardiovascular complications.
- Diabetic cardiomyopathy is a distinct cardiac dysfunction that occurs independently of coronary artery disease and hypertension.
- Mitochondrial dysfunction is increasingly recognized as a key contributor to the pathogenesis of diabetic cardiomyopathy.
Purpose of the Study:
- To investigate the impact of streptozotocin-induced diabetes on mitochondrial function in rat ventricular tissue.
- To assess the reversibility of diabetes-induced mitochondrial alterations following insulin therapy.
- To explore the relationship between mitochondrial dysfunction and the development of diabetic cardiomyopathy.
Main Methods:
- Diabetes was induced in rats using streptozotocin (STZ) injection.
- Mitochondria were isolated from ventricular tissue 8 weeks post-STZ induction.
- Mitochondrial function was assessed by measuring state 3 respiration, oxidative phosphorylation, Mg2+-dependent ATPase activity, and calcium handling (uptake and binding).
- Reversibility was evaluated after 2 and 4 weeks of insulin treatment.
Main Results:
- Diabetic rat hearts exhibited depressed mitochondrial state 3 respiration, oxidative phosphorylation, and Mg2+-dependent ATPase activity.
- Mitochondrial calcium uptake, but not calcium binding, was significantly decreased in diabetic hearts.
- These functional deficits were partially reversible after 2 weeks and fully reversible after 4 weeks of insulin therapy.
- Observed mitochondrial dysfunction could not be attributed to changes in lipid/protein composition or contamination.
Conclusions:
- Chronic diabetes leads to a generalized depression of mitochondrial function in the heart.
- This mitochondrial dysfunction is a key factor contributing to the development of diabetic cardiomyopathy.
- Insulin therapy demonstrates potential for reversing diabetes-associated mitochondrial defects and mitigating cardiac dysfunction.